PCI Biotech: Successful Phase I fimaVacc vaccination proof of concept study to be published in Frontiers in Immunology
November 23, 2020 02:30 ET
|
PCI Biotech Holding ASA
Oslo (Norway), 23 November 2020 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company, today announced that the results from the successful Phase I proof of concept study for the...
Global Cancer Vaccines Market (2020 to 2027) - by Technology, Type, Indication, End-user and Geography
October 28, 2020 08:43 ET
|
Research and Markets
Dublin, Oct. 28, 2020 (GLOBE NEWSWIRE) -- The "Cancer Vaccines Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Technology, Type, Indication, End User and Geography" report has been...
Insights on the Dendritic Cell Cancer Vaccine Immunotherapy Global Market to 2026
October 22, 2020 04:33 ET
|
Research and Markets
Dublin, Oct. 22, 2020 (GLOBE NEWSWIRE) -- The "Global Dendritic Cell Cancer Vaccine Immunotherapy Market, Dosage, Price & Clinical Trials Insight 2026" report has been added to...
Global Cancer Vaccines Market (2020 to 2025) - Main Drivers and Restraints
September 15, 2020 07:08 ET
|
Research and Markets
Dublin, Sept. 15, 2020 (GLOBE NEWSWIRE) -- The "Cancer Vaccines Market, Pipeline Analysis Report 2020" report has been added to ResearchAndMarkets.com's offering. This report provides a...
Insights on the Cancer Vaccines Global Market to 2027 - Opportunity Analysis and Industry Forecast
September 04, 2020 07:09 ET
|
Research and Markets
Dublin, Sept. 04, 2020 (GLOBE NEWSWIRE) -- The "Cancer Vaccines Market by Technology, Type, Indication and End User: Global Opportunity Analysis and Industry Forecast, 2020-2027" report has been...
PCI Biotech: US patent for the vaccine technology (fimaVacc) with a new important class of adjuvants
March 26, 2020 04:12 ET
|
PCI Biotech Holding ASA
Oslo (Norway), 26 March 2020 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company, today announces that the U.S. Patent and Trademark Office (USPTO) has informed the company that a...
PCI Biotech's fourth quarter and preliminary 2019 results
February 26, 2020 01:00 ET
|
PCI Biotech Holding ASA
Oslo (Norway), 26 February 2020 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company, today announces its interim fourth quarter and preliminary 2019 results. Please find enclosed the...
PCI Biotech: US patent granted for the vaccine technology (fimaVacc) in combination with cytokines
January 21, 2020 02:00 ET
|
PCI Biotech Holding ASA
Oslo (Norway), 21 January 2020 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company, today announces that the U.S. Patent and Trademark Office (USPTO) has granted the company a US...
Oncotelic Inc. Announces Appointment of Fatih Uckun MD PhD to Chief Medical Officer
January 22, 2019 09:15 ET
|
Oncotelic Inc
AGOURA HILLS, Calif, Jan. 22, 2019 (GLOBE NEWSWIRE) -- Oncotelic Inc. (“Oncotelic), a privately held cancer immunotherapy company dedicated to the discovery and development of in situ cancer...
Sirona Biochem Announces Addition of Dr. Brett Premack as Scientific Consultant
March 14, 2012 09:00 ET
|
Sirona Biochem Corp.
VANCOUVER, BRITISH COLUMBIA--(Marketwire - March 14, 2012) - Sirona Biochem Corp. (TSX VENTURE:SBM)(PINKSHEETS:SRBCF)(FRANKFURT:ZSB), a biotechnology company specializing in carbohydrate...